financetom
Business
financetom
/
Business
/
AbbVie says blood cancer drug fails late-stage trial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AbbVie says blood cancer drug fails late-stage trial
Jun 16, 2025 6:25 AM

June 16 (Reuters) -

AbbVie ( ABBV ) said on Monday its treatment for a group of

blood cancers failed to meet the main goal of overall survival

in a late-stage trial.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BHP removes striking workers at huge Chile copper mine, output at risk
BHP removes striking workers at huge Chile copper mine, output at risk
Aug 13, 2024
SANTIAGO, Aug 13 (Reuters) - Mining giant BHP said on Tuesday it had started removing workers on strike at its Escondida copper mine in Chile, deepening tensions at the site after a powerful union rejected the company's latest invitation for talks on pay. The strike at the world's largest copper mine was declared hours earlier after negotiations collapsed and could...
California allows Chinese robotaxi firm WeRide to test with passengers
California allows Chinese robotaxi firm WeRide to test with passengers
Aug 13, 2024
(Reuters) - China-based autonomous driving startup WeRide has received approval from California to test its driverless vehicles with passengers, according to a permit from the state's utility regulator. The move comes as the company seeks a valuation of as much as $5 billion from its New York IPO even as the U.S. is set to ban vehicles with China-developed systems,...
Elliott targets Southwest Airlines board in bid to shake up leadership
Elliott targets Southwest Airlines board in bid to shake up leadership
Aug 13, 2024
NEW YORK, Aug 13 (Reuters) - Elliott Investment Management has launched a boardroom battle at Southwest Airlines ( LUV ) , seeking to replace as many as 10 directors as the hedge fund pushes to oust the airline's chief executive and improve performance, Elliott said on Tuesday. The hedge fund has been interviewing candidates for Southwest's ( LUV ) 15-member...
California allows Chinese robotaxi firm WeRide to test with passengers
California allows Chinese robotaxi firm WeRide to test with passengers
Aug 13, 2024
Aug 13 (Reuters) - China-based autonomous driving startup WeRide has received approval from California to test its driverless vehicles with passengers, according to a permit from the state's utility regulator. The move comes as the company seeks a valuation of as much as $5 billion from its New York IPO even as the U.S. is set to ban vehicles with...
Copyright 2023-2025 - www.financetom.com All Rights Reserved